Also, the number of bacteremias found in the two groups was unequal; 16 among the patients receiving polymyxin-B hemo-perfusion versus only 3 among the patients receiving conventional therapy, a highly significant and unexplained imbalance.
← all excerpts
Towards clinical applications of anti-endotoxin antibodies; a re-appraisal of the disconnect.
1
—
—